Get the Stockscreener App
8.07
0.37%
-0.03
After Hours:
8.20
0.13
+1.61%
Endra Life Sciences Inc stock is traded at $8.07, with a volume of 90,993.
It is down -0.37% in the last 24 hours and up +133.91% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$8.10
Open:
$8.1
24h Volume:
90,993
Relative Volume:
0.06
Market Cap:
$5.96M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.0117
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
+133.47%
1M Performance:
+133.91%
6M Performance:
+36.32%
1Y Performance:
-94.95%
1-Day Range:
$7.82
$8.44
1-Week Range:
$6.60
$11.96
52-Week Range:
$2.90
$170.62
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
8.07 | 2.55M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
425.34 | 158.06B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.75 | 142.87B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
531.42 | 43.87B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.08 | 33.87B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
160.13 | 28.10B | 15.50B | 1.33B | 2.16B | 7.34 |
Endra Life Sciences Inc Stock (NDRA) Latest News
Helius Medical Tech Stock Price, Quotes and Forecasts | NASDAQ:HSDT - Benzinga
Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - inkl
Why Is AbbVie Stock Trading Higher On Thursday? - inkl
Endra Life Sciences Plunges 13.46% Post Reverse Split - AInvest
NDRA SEC FilingsEndra Life Sciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - inkl
Gold Falls 1%; ProKidney Shares Spike Higher - Benzinga
MAG 7 Undercard: $5 Stocks to Watch – NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside - FinancialContent
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday - inkl
Endra Life Sciences shares surge 136.62% intraday after announcing a new patent and strategic focus on GLP-1 drug trials. - AInvest
ENDRA’s TAEUS Advancement: A New Era in Liver Imaging? - timothysykes.com
US Stocks Mixed; Small Business Sentiment Falls In June - Benzinga
Endra’s Recent Surge: What’s Fueling the Rise? - StocksToTrade
Endra Life Sciences Soars 144.14% on Investor Interest - AInvest
Endra Life Sciences Soars 86.87% on Market Optimism - AInvest
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - inkl
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - inkl
NDRA Director Granted 5,384 RSUs in Latest Form 4 Filing - Stock Titan
ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancem - GuruFocus
ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard | NDRA Stock News - GuruFocus
ENDRA's Revolutionary Liver Imaging Technology Achieves Major Breakthrough in 100+ Patient Study - Stock Titan
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ENDRA Life Sciences Unveils New Business Strategy - TipRanks
Wall Street Zen Upgrades ENDRA Life Sciences (NASDAQ:NDRA) to Hold - Defense World
Ascendiant Capital Maintains Buy Rating on ENDRA Life Sciences (NDRA) | NDRA Stock News - GuruFocus
Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
ENDRA Life Sciences Faces Nasdaq Compliance Challenge - TipRanks
ENDRA Life Sciences: Strategic Shift and Financial Update - TipRanks
ENDRA Life Sciences Provides a Business Update and Reports First - GuruFocus
ENDRA Life Sciences (NDRA) Aims to Revolutionize Metabolic Disease Detection | NDRA Stock News - GuruFocus
ENDRA Life Sciences Q1 2025 Financial Results and Business Update - TradingView
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year - TipRanks
ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results - marketscreener.com
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Stock Titan
ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday - Defense World
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Highs and Lows in the Market - investchronicle.com
What is ENDRA Life Sciences Inc (NDRA) Stock Return on Shareholders’ Capital? - Sete News
What Are You Thinking About Investing In ENDRA Life Sciences Inc (NASDAQ: NDRA) Stock? - Stocksregister
ENDRA Life Sciences Inc: Navigating Market Fluctuations with a 1.74M Market Cap - investchronicle.com
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
ENDRA Life Sciences Deploys TAEUS Tech to Improve Metabolic Disease Detection - Medical Product Outsourcing
A Guide To The Risks Of Investing In ENDRA Life Sciences Inc (NDRA) - knoxdaily.com
ENDRA Life Sciences (NASDAQ:NDRA) Given New $50.00 Price Target at Ascendiant Capital Markets - Defense World
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
13.81%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):